The novel coronavirus disease COVID-19 is produced by SARS-CoV-2. WHO has declared COVID-19 as a public health emergency, with the most susceptible populations (requiring ventilation) being the elderly, pregnant women and people with associated co-morbidities including heart failure, uncontrolled diabetes, chronic obstructive pulmonary disease, asthma and cancer. However, such general guidance does not provide information regarding COVID-19 risks in patients with suffering from pre-existing thyroid problems, and furthermore, we do not know whether patients with COVID-19 (symptomatic or without symptoms), who have not previously had thyroid issues develop endocrine thyroid dysfunction after infection. The European Society for Endocrinology recently published a statement on COVID-19 and endocrine diseases ( Endocrine , 2020); however, thyroid diseases were not mentioned specifically. We have therefore reviewed the current literature on thyroid diseases (excluding cancer) and COVID-19, including data from the previous coronavirus pandemic caused by the SARS-associated coronavirus (SARS-CoV), a member of the same family Coronaviridae leading to severe acute respiratory syndrome (SARS). At the moment there are no data suggesting that thyroid patients are at higher risk of COVID-19, but this requites further research and data analysis.
【저자키워드】 COVID-19, Thyroid, Thyroid autoimmune disease, AITD, 【초록키워드】 SARS-CoV-2, Asthma, coronavirus, pandemic, SARS-CoV, Cancer, Infection, Ventilation, risk, diabetes, novel coronavirus disease, Population, pregnant women, endocrinology, heart failure, symptomatic, Research, Patient, Data analysis, co-morbidity, WHO, public health emergency, information, disease, Guidance, pulmonary disease, Endocrine, dysfunction, Society, acute respiratory syndrome, higher risk, problems, family Coronaviridae, susceptible, European, produced, develop, caused, chronic obstructive, endocrine disease, patients with COVID-19, without symptoms, 【제목키워드】 thyroid disease,